SCHEMBL13087653

SCHEMBL13087653

CS(=O)(=O)N1CCC(Oc2cc(-c3ccccc3)cc3ccncc23)CC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IKBKB O14920 8/20 0.56
CHUK O15111 5/20 0.56
ALDH1A1 P00352 4/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
LCK P06239 1/20 0.41
ROCK1 Q13464 1/20 0.41
LMNA P02545 1/20 0.41
CACNB4 O00305 1/20 0.40
CACNA1A O00555 1/20 0.40
CACNA1G O43497 1/20 0.40
CACNG3 O60359 1/20 0.40
CACNA1F O60840 1/20 0.40
CACNA1H O95180 1/20 0.40
CACNB3 P54284 1/20 0.40
CACNA2D1 P54289 1/20 0.40
CACNG7 P62955 1/20 0.40
CACNA1B Q00975 1/20 0.40
CACNA1D Q01668 1/20 0.40
CACNB1 Q02641 1/20 0.40
CACNG1 Q06432 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13088172 0.94 IKBKB (0.49) IKBKBCHUKALDH1A1L3MBTL1LMNA
SCHEMBL13087784 0.93 IKBKB (0.51) IKBKBCHUKALDH1A1L3MBTL1LMNA
SCHEMBL13087926 0.91 IKBKB (0.69) IKBKBCHUKALDH1A1L3MBTL1LCK
SCHEMBL13087783 0.90 IKBKB (0.48) IKBKBCHUKALDH1A1L3MBTL1LMNA
SCHEMBL13087965 0.90 IKBKB (0.54) IKBKBCHUKLCKROCK1CACNB4
SCHEMBL13087933 0.89 IKBKB (0.48) IKBKBCHUKALDH1A1L3MBTL1CACNB4
SCHEMBL13087858 0.89 IKBKB (0.48) IKBKBCHUKALDH1A1L3MBTL1RORC
SCHEMBL13087929 0.88 IKBKB (0.49) IKBKBCHUKALDH1A1L3MBTL1CACNB4
SCHEMBL13087936 0.88 IKBKB (0.48) IKBKBCHUKALDH1A1L3MBTL1CACNB4
SCHEMBL13087666 0.87 IKBKB (0.48) IKBKBCHUKALDH1A1L3MBTL1LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8299055-B2 8-substituted isoquinoline derivative and the use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2012-10-30 US disclosed
US-8299055-B2 8-substituted isoquinoline derivative and the use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2012-10-30 US disclosed
US-20100261701-A1 8-Substituted isoquinoline derivative and the use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2010-10-14 US disclosed
US-20100261701-A1 8-Substituted isoquinoline derivative and the use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2010-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100261701-A1 8-Substituted isoquinoline derivative and the use thereof RELA, NFKBIA, NFKB2 IKBKB 7/4885CHUK 17/4885ALDH1A1 1380/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.